Edition:
United Kingdom

ContraVir Pharmaceuticals Inc (CTRV.OQ)

CTRV.OQ on NASDAQ Stock Exchange Capital Market

4.17USD
7:42pm BST
Change (% chg)

$-0.41 (-8.95%)
Prev Close
$4.58
Open
$4.50
Day's High
$4.52
Day's Low
$4.10
Volume
118,224
Avg. Vol
127,544
52-wk High
$107.10
52-wk Low
$4.10

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 0.00 -8.026
FY 2018 Dec '18 0.00 -7.297
Sep '18 0.00 -44.258
Jun '18 0.00 -26.439
Mar '18 0.00 -18.597
FY 2017 Dec '17 0.00 -9.720
Sep '17 0.00 -42.212
Sep '17 0.00 -0.075
Dec 0.00 -42.001
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 104.70 37.22
P/E High - Last 5 Yrs. -- 161.48 57.50
P/E Low - Last 5 Yrs. -- 50.92 28.56
Beta 1.05 1.19 0.96
Price to Sales (TTM) -- 42.02 11.26
Price to Book (MRQ) -- 12.44 4.52
Price to Tangible Book (MRQ) -- 18.29 5.33
Price to Cash Flow (TTM) -- 69.03 25.90
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.10 1.62
Dividend Yield - 5 Year Avg -- 0.05 1.35
Dividend 5 Year Growth Rate -- 0.76 6.51
Payout Ratio(TTM) -- 1.44 39.77

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 58.53 15.47
Sales (TTM) vs TTM 1 Yr. Ago -- 47.79 8.81
Sales - 5 Yr. Growth Rate -- 33.21 10.36
EPS (MRQ) vs Qtr. 1 Yr. Ago 56.84 -8.70 18.33
EPS (TTM) vs TTM 1 Yr. Ago -57.52 -- --
EPS - 5 Yr. Growth Rate -- 21.99 7.10
Capital Spending - 5 Yr. Growth Rate -- 24.47 7.91

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.74 2.47
Current Ratio (MRQ) 0.55 3.73 3.43
LT Debt to Equity (MRQ) 0.00 7.68 14.20
Total Debt to Equity (MRQ) 294.81 21.11 19.90
Interest Coverage (TTM) -- 36.26 15.19

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 26.34 49.98
Gross Margin - 5 Yr. Avg. -- 59.85 51.24
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -5.94 16.31
Operating Margin (TTM) -- -109.20 -10.49
Operating Margin - 5 Yr. Avg. -- -22.20 11.55
Pre-Tax Margin (TTM) -- -110.56 -10.99
Pre-Tax Margin - 5 Yr. Avg. -- -27.53 16.30
Net Profit Margin (TTM) -- -116.19 -14.78
Net Profit Margin - 5 Yr. Avg. -- -32.94 11.48
Effective Tax Rate (TTM) -- 17.23 20.19
Effective Tax Rate - 5 Yr. Avg. -- 18.85 24.40

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 8,199,417 794,118,785
Net Income/Employee (TTM) -588,751 1,747,035 93,433,457
Receivable Turnover (TTM) -- 10.85 5.83
Inventory Turnover (TTM) -- 2.42 3.68
Asset Turnover (TTM) 0.00 0.33 0.82

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -95.28 6.38 9.76
Return on Assets - 5 Yr. Avg. -- 6.29 10.70
Return on Investment (TTM) -146.13 7.78 12.18
Return on Investment - 5 Yr. Avg. -- 8.24 13.61
Return on Equity (TTM) -3,746.07 8.33 17.03
Return on Equity - 5 Yr. Avg. -- 9.27 15.11
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -- -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for ContraVir Pharmaceuticals Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -44.61 -46.79 12 93
13 Week -71.61 -72.58 9 90
26 Week -77.04 -81.50 9 32
52 Week -95.61 -95.91 6 8
YTD -76.80 -80.06 9 15
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 0.79%
# of Holders: 21
Total Shares Held: 6,347
3 Mo. Net Change: -4,656
# New Positions: 1
# Closed Positions: 3
# Increased Positions: 2
# Reduced Positions: 11
# Net Buyers: -9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.